PRTA News Alert Prothena Corporation Plc (PRTA) 20.14 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Prothena Corporation Plc (PRTA) 20.14 $PRTA

Prothena Corp. (PRTA) Looks Good: Stock Moves Up 5.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 22, 7:51AM CST
Prothena Corporation plc (PRTA) was a big mover last session, as its shares rose almost 6% on the day.
BIIB: 340.89 (+5.13), PRTA: 20.14 (+1.41)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 4:37PM CST

NOW: 69.69 (+0.12), WIT: 11.81 (-0.05), AG: 4.77 (+0.21), DGII: 9.15 (+0.15), BBEP: 7.06 (-0.23), NGD: 4.18 (+0.16), IAG: 2.41 (+0.06), VIIX: 38.17 (-0.37), PRTA: 20.14 (+1.41), CDE: 5.11 (+0.31)

Prothena mAb Fast Track'd for AL Amyloidosis
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 4:05PM CST

PRTA: 20.14 (+1.41)

Prothena Receives FDA Fast Track Designation for NEOD001, a Monoclonal Antibody for the Treatment of Patients With AL Amyloidosis
GlobeNewswire - Mon Dec 15, 3:10PM CST
-- First Investigational Immunotherapy for AL Amyloidosis to Receive FDA Fast Track Designation
PRTA: 20.14 (+1.41)

Commit To Purchase Prothena Corp At $17.50, Earn 33.1% Annualized Using Options
at The Street - Fri Dec 12, 10:45AM CST
Investors considering a purchase of Prothena Corp plc shares, but tentative about paying the going market price of $17.97/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put...
PRTA: 20.14 (+1.41)

First patient enrolled in Acorda Phase 3 PD trial
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 7:06AM CST

IPXL: 31.32 (+0.26), ADMS: 16.10 (+1.45), TEVA: 57.09 (+0.33), ACOR: 39.14 (+0.74), PRTA: 20.14 (+1.41), NDRM: 5.90 (-0.19)

Prothena to Present at the Oppenheimer 25th Annual Healthcare Conference in New York
GlobeNewswire - Mon Dec 08, 4:11PM CST
Prothena Corporation plc (Nasdaq RTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve amyloid or cell adhesion, announced that Tran Nguyen, the Company's Chief Financial Officer, will be presenting at the Oppenheimer 25 Annual Healthcare Conference on Thursday, December 11, 2014, at 10:55 AM EST. The conference will be held at the Crowne Plaza Hotel in New York.
PRTA: 20.14 (+1.41)

Prothena Corporation (PRTA) Falls: Stock Goes Down 5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 7:37AM CST
Shares of Prothena Corporation (PRTA) fell over 5% on the day. This continues the most recent downtrend for PRTA, as the stock is down over 9% since Nov 28. Although this slump was obviously disappointing the company has seen positive revisions and its current year loss consensus has narrowed over the past few weeks.
BIIB: 340.89 (+5.13), ANIP: 55.24 (+1.79), PRTA: 20.14 (+1.41), AFFX: 9.80 (+0.05)

Prothena Initiates NEOD001 Global Phase 3 Registrational Trial Based on Positive Results in Ongoing Phase 1/2 Study of NEOD001 in Patients With AL Amyloidosis
Thomson Reuters ONE - Tue Dec 02, 3:05PM CST
- New and Updated Results Show 50% Response Rate in 14 Cardiac-Evaluable Patients
PRTA: 20.14 (+1.41)

Why You Shouldn't Bet Against Prothena Corporation (PRTA) Stock - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 01, 7:43AM CST
Prothena Corporation might be an intriguing choice for investors as it is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective
PRTA: 20.14 (+1.41)

Prothena's Management Presents at 2014 Credit Suisse Healthcare Conference (Transcript)
SA Transcripts - at Seeking Alpha - Tue Nov 11, 2:16PM CST

PRTA: 20.14 (+1.41)

Prothena Reports Third Quarter 2014 Financial Results and R&D Progress
GlobeNewswire - Mon Nov 03, 5:29PM CST
-- Net cash used in operating activities was $12.3 million in the third quarter, while quarter-end cash position of $306.2 million provides solid runway for advancement of multiple programs
PRTA: 20.14 (+1.41)

Prothena beats by $0.12, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 4:06PM CST

PRTA: 20.14 (+1.41)

Genervon ALS drug shows encouraging results
Seeking Alpha - at Seeking Alpha - Mon Oct 20, 7:27AM CDT

BIIB: 340.89 (+5.13), MNOV: 3.04 (unch), CHTP: 6.52 (-0.03), ADMS: 16.10 (+1.45), ACOR: 39.14 (+0.74), BCLI: 3.85 (+0.22), BSX: 13.13 (+0.07), IPXL: 31.32 (+0.26), AVNR: 16.91 (+0.01), ACAD: 30.95 (+0.78), CVTS: (), MRK: 57.46 (+0.25), TEVA: 57.09 (+0.33), PRTA: 20.14 (+1.41), PRAN: 1.74 (-0.02), FOLD: 7.94 (+0.06), CUR: 2.70 (+0.07)

The Next Biotech Buyout Stock
Motley Fool Staff - Motley Fool - Fri Oct 10, 7:15AM CDT
Biotech stocks are notoriously volatile, making them best suited for only the most risk-tolerant investors. But for those willing to take the risk, biotech companies can often make a big splash; particularly when a bigger fish gobbles them up....
JNJ: 104.59 (+0.31), PTLA: 28.35 (+0.21), PFE: 31.42 (-0.03), BMY: 59.15 (-0.01), PRTA: 20.14 (+1.41), PBYI: 189.96 (+0.12)

Why Prothena Corporation (PRTA) Stock Might be a Great Pick - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 7:43AM CDT
Prothena Corporation belongs to the Medical and Biomedical industry, is a decent pick as it witnessed solid earnings estimate revision activity with a favorable Zacks Industry Rank.
PRTA: 20.14 (+1.41)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pepsi Faces Georgia Labor Pressure Ahead of Strike

Updated Category News Views 121

A Pre-Dawn Labor Test Is Brewing in Georgia At 2:30 in the morning, nobody gathers outside a distribution center for the scenery. More than 100 Pepsi-Cola drivers from Atlanta and Lithonia are slated to meet Tuesday, November 24, at the Pepsi Distribution Center in Lithonia, Georgia, with Teamsters General President Sean M. O'Brien joining them. That hour matters. It puts...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 65

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
S&P Global's December 8 Talk Puts Guidance in Focus

Updated Category News Views 71

A 35-minute fireside chat can be a whole lot of nothing, or it can leave a useful breadcrumb trail for shareholders willing to listen closely. S&P Global has put December 8, 2026 on the calendar, when Chief Executive Officer Martina Cheung is scheduled to appear at Goldman Sachs' 2026 Financial Services Conference in New York. Her slot runs from 5:00 p.m. to 5:35 p.m....

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 94

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 104

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 125

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
DISA Backs Nursing Education With OADN Foundation Push

Updated Category News Views 79

A nursing workforce does not appear by magic when hospitals need it most; somebody has to help students, instructors, and programs survive the long haul before that first shift. DISA's newly announced partnership with the Organization for Associate Degree Nursing and the OADN Foundation is aimed squarely at that unglamorous, essential stretch of the pipeline. For a sector...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 160

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 162

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 85

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading

Top 5 Most Recently Viewed Articles

GLS and APES Join Forces in Semiconductor Packaging Venture

Updated Category News Views 203

Opportunities and Risks in the Semiconductor Landscape Alright, let’s get into it. Great Lakes Semiconductor (GLS) teaming up with Advanced Printed Electronic Solutions (APES) sounds like a match made in tech heaven, but it also raises some eyebrows. Personally, I’ve been around the block enough to recognize that in this line of business, one misstep can feel like a...

Continue Reading
Renaissance Acquires Ansel Health, Enhancing Insurance Solutions

Updated Category News Views 176

Renaissance's Strategic Acquisition of Ansel Health Renaissance Life & Health Insurance Company of America has recently acquired Ansel Health, a transformative technology company in the supplemental health insurance domain. Innovating Health Insurance Solutions This acquisition not only enhances Renaissance's service portfolio but also promises to lead the way in...

Continue Reading
High-Trend International Group's Revenue Soars with New Strategies

Updated Category News Views 199

High-Trend International Group Sees Massive Revenue Growth High-Trend International Group (NASDAQ: HTCO), a prominent name in ocean technology, has shared its impressive financial results. The Company has achieved a remarkable surge in revenue, marking a pivotal moment in its business journey. Understanding the latest financial summary showcases how effective new...

Continue Reading
Innovative Device Enhances At-Home Medical Exam Experience

Updated Category News Views 391

Revolutionizing Self-Exams with Innovative Design In today's fast-paced world, health awareness is more crucial than ever. Individuals often seek ways to monitor their health conveniently from the comfort of their home. Recognizing this need, an inventive mind has developed a unique device aimed at simplifying personal health examinations. The MEDICAL EXAM WAIST BAND...

Continue Reading
Navitas Unveils Groundbreaking Power Supply for AI Data Centers

Updated Category News Views 86

Navitas Semiconductor Makes Waves in AI Power Supply Solutions Navitas Semiconductor, a trailblazer in power semiconductor technology, is set to impress at the upcoming power electronics conference in China. Their latest innovation, the world's first 8.5 kW AI data center power supply, integrates leading-edge gallium nitride (GaN) and silicon carbide (SiC) technologies....

Continue Reading